Investors & Media
The Medicines Company is a biopharmaceutical company driven by an overriding purpose—to save lives and alleviate suffering by developing solutions for diseases with vast economic and social consequences. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers. To learn more about The Medicines Company and our work driving innovation in the cardiovascular disease space, visit our media toolkit here.
Press Releases
06 Nov 2019The Medicines Company to Present Inclisiran Data from ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies at American Heart Association Scientific Sessions 201930 Oct 2019The Medicines Company Reports Third-Quarter 2019 Financial Results and Achievement of Major Milestones for Inclisiran24 Oct 2019The Medicines Company to Announce Third Quarter 2019 Financial Results on October 30
View All